On TRAC with charity donations

Cornish Regulatory Affairs Specialist raises £20,000 through volunteer project

TRAC Services has donated more than £20,000 to local charities, clubs and community projects in Cornwall through a special volunteer project.

The Camborne, UK-based company, which works with pharmaceutical manufacturers around the world, has donated £22,000 since launching a pioneering project in 2006 in which volunteers across Cornwall raised funds for a charity or community group in return for a 30-minute question and answer session.

The project was launched four years ago to enable pharmaceutical companies to get feedback on Patient Information Leaflets from members of the public, and gave everyone taking part the opportunity to raise money by donating £20 to a nominated charity or group.

More than 50 community groups such as Cornwall Blind Association, St Agnes Football Club, Truro Fencing Club, Cornwall Air Ambulance, and Camborne Bowling Association have all had their funds boosted by the volunteer scheme.

TRAC Director Sarah Trethowan said: ‘When we came up with the idea of running the volunteer project we really didn’t know if it would take off, but are absolutely thrilled that we have been able to donate £22,000 to good causes and community projects in Cornwall.

‘The beauty of the volunteer project was that not only did every person taking part in it raise £20 towards their nominated cause but by taking part they were also helping to improve the way pharmaceutical companies produce information leaflets, making them clearer and easier to understand.’

With the project now coming to an end, TRAC is continuing its charity work by becoming a member of Cornwall Community Foundation’s 100 Club, which has been launched to enable businesses in the county to help fund grassroots organisations and projects.

TRAC recently became the second firm in Cornwall to achieve a Silver Investors in People (IIP) standard. It also took top honours in the Graduate Development Category at the Cornwall Excellence in Business Training Awards 2010.

You may also like

Regulatory

CStone's sugemalimab approved by MHRA for Stage III NSCLC

The MHRA's decision marks the biopharma's second indication approved for the product in the UK, with a global commercial rollout for sugemalimab now actively underway
Regulatory

American Chemistry Council's statement to Trump: make chemistry in America again

The Council has released a statement ahead of the President's State of the Union Address, asking for policies that unlock domestic production and address unfair foreign practices
Regulatory

Johnson & Johnson files FDA application for IMAAVY in wAIHA

Johnson & Johnson has submitted an sBLA to the US Food and Drug Administration seeking approval of IMAAVY as the first-ever treatment for warm autoimmune haemolytic anaemia, supported by Phase II/III ENERGY trial data showing rapid and durable haemoglobin response
Regulatory

NICE approves Opzelura cream as first UK treatment for non-segmental vitiligo

Incyte Biosciences UK has secured NICE approval for Opzelura (ruxolitinib) cream, granting eligible NHS patients with non-segmental vitiligo access to the first and only approved therapy in England shown to support facial re-pigmentation
Regulatory

CDA-AMC rejects Leqembi reimbursement despite Health Canada approval

After expressing disappointment about a separate insomnia ruling, Eisai has criticised a draft decision by Canada's drug agency not to recommend public reimbursement of Leqembi for early Alzheimer's disease
Regulatory

Shield Therapeutics’ ACCRUFeR becomes first FDA-approved oral iron for children 10+

The FDA's approval for ACCRUFeR (ferric maltol) to treat iron deficiency in children aged 10 and older makes it the first and only prescription oral iron therapy specifically approved for this pediatric population
Regulatory

Hansa Biopharma’s imlifidase BLA accepted for FDA review

The US Food and Drug Administration has accepted the company's Biologics License Application for imlifidase, a novel IgG-cleaving enzyme designed to enable HLA-incompatible kidney transplantation
Subscribe now